DatasetName,RREB1_S(107) RREB1_S(1103) RREB1_S(1502) RREB1_S(1624) RREB1_S(848) RREB1_T(1121) RREB1_T(351),RREB1_S(1107) RREB1_S(111) RREB1_S(1110) RREB1_S(1122) RREB1_S(1134) RREB1_S(1135) RREB1_S(1140) RREB1_S(1164) RREB1_S(1167) RREB1_S(1174) RREB1_S(1175) RREB1_S(12) RREB1_S(120) RREB1_S(1219) RREB1_S(1225) RREB1_S(1235) RREB1_S(1238) RREB1_S(1303) RREB1_S(1320) RREB1_S(1375) RREB1_S(1388) RREB1_S(1475) RREB1_S(1479) RREB1_S(149) RREB1_S(1499) RREB1_S(1530) RREB1_S(1575) RREB1_S(161) RREB1_S(1653) RREB1_S(1681) RREB1_S(17) RREB1_S(172) RREB1_S(175) RREB1_S(180) RREB1_S(191) RREB1_S(231) RREB1_S(29) RREB1_S(36) RREB1_S(41) RREB1_S(42) RREB1_S(669) RREB1_S(694) RREB1_T(1315) RREB1_T(1370) RREB1_T(1471) RREB1_T(29) RREB1_T(31) RREB1_Y(1239) RREB1_Y(706)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5250597710336252
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.531250214856778
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5223989626874024
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5235343280368312
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5271257259884086
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5299724807055015
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5305740486219478
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5323830879052027
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5205069100847189
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.530566075967354
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.525723842131379
RB2022_5_PreEndurance,,0.526147795421637
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5248442393013739
WZ2023_Pu_010_30min,,0.517881283927036
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5279470380202118
RB2022_8_RecoveryEndurance,,0.5256687398580667
KBE2022_Log2_Ex_14_U,,0.5273592131103149
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5202360124139519
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.5252244095345859
RB2022_5_PreSprint,,0.5226207014750421
PG2020_Intensity 8h_C,,0.5216756790742905
AH2018_SILAC_MR_2_N,,0.5245570633315895
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.522637644022737
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.5219381965494777
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5262056878979416
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5354109417908123
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.5250400135166736
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.5252004558402497
GF2025_P6_Sph,,0.5260683669136577
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5289612399223894
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5177891163891297
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5202855664831355
KBE2022_Log2_Ex_34_U,,0.5341062049086793
WZ2023_Pu_005_10min,,0.5179335392932771
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5246039412838348
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5234657908674314
WZ2023_Pu_025_30min,,0.519097510347151
AH2018_SILAC_MR_2_X,,0.5255681740090462
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5380889598784037
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.5230008229078861
EJN2021_3_Rest_Basal,,0.5233331245447425
CR2017_Ratio Replicate 1.3,,0.5337009237367156
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5210945093293423
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5225362772002192
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5283209067518633
AH2018_LFQ_1_C,,0.5272005530580791
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.5251533857583344
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.5157139349085483
CK2022_11 40-1,,0.5245458764971157
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5242798445387056
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.31904246929296015,0.5390738259593472
FSO2013_Ratio H/L normalized Rep2,,0.5261685201843823
WZ2023_Pu_005_20min,,0.5176916689224433
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.539128356480736
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5292032803498047
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,0.5231931287029953
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.5210817508155968
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5257720758447627
CK2022_1 200-1,,0.5267850172085956
PG2020_Intensity Mock_10h_D,,0.5090277225967027
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5261573737670419
RCJD2014_5min_1,,0.5280505425380184
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5412303309459778
PG2020_Intensity 2h_C,,0.5146785382927846
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5300173852419547
KBE2022_Log2_Ex_8_T,,0.5305654112726551
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5253273883668858
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5272032942980486
CK2022_3 40-1,,0.5240342894844425
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.3086667259061001,
HH2022_Reporter intensity 8,,0.517210662647398
ZQ2022_N2,,0.5284134943458424
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5294131969870476
EJN2021_5_Rest_Basal,,0.5235580920624184
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5215469407647959
YA2020_Reporter_intensity_Normal_No.1,0.3117007552325562,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.525824931845161
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5258015387125003
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5299793310388712
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5262568030678929
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5290082608937011
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.5212352013876912
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5237401369841951
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.523360245963141
KS2014_Intensity N3,0.30188772753434917,0.5326088464041252
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,0.525833461228774
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5216721856655733
FSO2013_Ratio H/M normalized Rep2,,0.5291344318717895
RAM2015_Log2 A,,0.5446365621796975
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5228100887646178
KS2014_Intensity E15_2,0.31202324560669564,0.5339462897676729
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5225481975071166
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5215031344875635
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.5275572322266862
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5248301671211548
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.5246636149146243
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5201698857489789
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.5256933026756352
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.5273371321971901
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5297939460024061
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5257673448435617
AH2018_SILAC_IT_3_X,,0.5226162793881357
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5263679257797693
FSO2013_Ratio M/L normalized Rep2,,0.530415532369751
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5225259522940322
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5233292180504607
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5222481234509944
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5237175442622123
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5334127950310505
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5195593672476824
EJN2021_4_Rest_Ins,,0.5233799843390766
RN2012_H05,,0.5286796439775403
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.527744459999299
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.5261365121458264
EJN2021_1_Rest_Ins,,0.5224161569170328
HH2022_Reporter intensity 3,,0.5340749310153604
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5230796756343328
JW2021_After_3,,
GF2025_P8_Sph,,0.5279651821493813
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5246158960409482
CK2022_11 200-1,,0.5352343836228041
CK2022_12 200-1,,0.5362379987950668
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5208882510914129
WZ2023_Su_010_20min,,0.5212551394229058
AH2018_TMTMS2_2_N,,0.5209216497784239
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5338598209387165
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5266220284547758
AH2018_TMTMS3_Pool,,0.5303269885738905
KS2014_Intensity N4,0.32200497932786093,0.5276361868702425
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.5282806503413674
CK2022_14 200-1,,0.5259199486660718
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5242007397838833
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5315750518935772
AST2020_anti-CD3+PDL2.2,,0.520191096183208
PG2020_Intensity Mock_10h_A,,0.5097388587473543
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.5236398897173562
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.5255414057930069
GF2025_P1_Adh,,0.524284557365114
GF2025_P1_Sph,,0.5233896461667632
EJN2021_5_Ex_Basal,,0.5245421228375606
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5167534793346589
CF2017_EOC 1,,0.5327771713757028
CK2022_3 200-1,,0.5267073083913963
AH2018_LFQ_IT_3_C,,0.5262943345435959
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.5225839943823266
RB2022_3_RecoverySprint,,0.5269859321735966
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.5214281963657026
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5235363712955465
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5264746128602681
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5226201418480956
AR2021_ALG 1 μM,,0.5259641175136128
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.5229455393868582
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5270049886032008
CR2017_Ratio Replicate 3.2,,0.5327788100983586
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5256873386332014
CK2022_9 16-1,,0.5262774449562694
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.5252538202647591
CK2022_13 200-1,,0.5250148077674407
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5200176424711078
CK2022_16 16-1,,0.5250775590370146
FS2019_db/db3,,
CK2022_15 40-1,,0.5228784015366845
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5181357260128108
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5334646912765985
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.524253827452014
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5309032219449688
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5310250146706623
AH2018_LFQ_M_1_N,,0.5283909806309771
KBE2022_Log2_Ex_27_U,,0.5271971134023745
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5159563845934572
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5276150312772039
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.5242437521846782
YA2020_Reporter_intensity_Normal_No.4,0.3035388886827212,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5241889893360694
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.525758808561324
RN2012_L13,,0.5256582588855861
LG2023_Control-1_intensity,,0.5270551612385829
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.5279223869412802
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5303413493164226
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5249176432188921
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5207980707872778
HH2022_Reporter intensity 6,,0.5200003134887502
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,0.5255439450887341
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5242690755740698
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5209890954277473
GF2025_P3_Adh,,0.5255295794548839
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5226621827014092
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5268294979842388
KBE2022_Log2_Ex_19_U,,0.5283117094037015
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.5248691954651599
YA2020_Reporter_intensity_Cancer_No.1,0.31644683548570324,
AST2020_Control,,0.5196999923157062
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5199723245372797
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5324808987058173
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.5260653160481898
RB2022_5_RecoverySprint,,0.5250137742997809
RB2022_7_RecoverySprint,,0.5235730719181756
YA2020_Reporter_intensity_Normal_No.3,0.3123939107495148,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5258059171068852
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.5196789498124684
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.31109910307264454,0.5285410953748613
HH2022_Reporter intensity 1,,0.5339139716805343
HH2022_Reporter intensity 2,,0.531740931159715
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.3066745610348667,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5323869666046614
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5234626091894591
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5336945523153449
AR2021_KD 72h,,0.54292711933768
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.526324076738308
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5284607887090524
KBE2022_Log2_Ex_9_U,,0.5272946705925048
AH2018_SILAC_M_3_N,,0.5219302809433909
KBE2022_Log2_Ex_13_T,,0.5307305654740807
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5105810107741494
CF2017_OSE 29,,0.5221967311405022
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.5267075635006595
RN2012_L12,,0.5222983172135881
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5234879862370487
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5251428183809096
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.5268961143712091
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5253515568977148
RB2022_7_RecoveryEndurance,,0.5257968616568125
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5234949687425511
TM2022_S2.12h.B,,
RN2012_L15,,0.5258731016118348
KS2014_Intensity pY_PV3,,0.5217547396823253
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5244144664230874
FSO2013_Ratio H/M normalized Rep2___2,,0.5290926499280479
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.5322772005534249
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5421573058418293
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.5209232626981232
CK2022_5 200-1,,0.5213065767427741
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5263799093875919
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5257508108535089
AH2018_SILAC_MR_1_X,,0.5256428881409128
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.5345851977604333
AH2018_SILAC_3_C,,0.5234928508549438
EJN2021_5_Rest_Ins,,0.5237364212469757
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.521925301052838
CK2022_4 16-1,,0.5262566800491971
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5227179400405871
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.526621641285247
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5260811369826935
FSO2013_Ratio H/L normalized Rep3,,0.5331314211588732
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.5279529108480613
AH2018_SILAC_IT_2_N,,0.5190507983400354
AH2018_SILAC_IT_1_X,,0.5240468672436055
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5257208701594207
WZ2023_Pe_025_20min,,0.5114246581431929
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5243637805683383
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5207228990943749
RN2012_H06,,0.5279342827088561
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.5184489545158943
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5297984743490228
WZ2023_Su_025_10min,,0.5164915112726901
AH2018_LFQ_IT_4_X,,0.5210774976151157
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.517112477256854
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.5252864019434168
EP2017_Pervanadate R#1 log2 ratio,,0.5270050758505096
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.3056070400742635,0.5406692724210486
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.522058629619721
LY2019_P7+,,0.5233698257910409
EP2017_Untreated R#1 normalized log2 ratio,,0.5310887154164072
RN2012_L10,,0.5284573782879683
PG2020_Intensity 4h_C,,0.5233418207482959
EP2017_Mitotic R#3 normalized log2 ratio,,0.5246225389105245
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5328497304535689
RB2022_8_PostStrength,,0.5269607010308691
AH2018_SILAC_IT_2_X,,0.5223155486159421
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.5264425674562415
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5233348930785149
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5250649932937089
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.526757785492864
GF2025_P9_Sph,,0.5235179717127733
CK2022_6 200-1,,0.5206619469711095
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5299411826812745
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5190996010429961
EP2017_Untreated R#3 normalized log2 ratio,,0.5254775125515735
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5211773936465492
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5444054126351333
RB2022_7_PostEndurance,,0.5235392035545531
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5341348201185072
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.5216838029399022
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5263327842484667
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.5280170769930027
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5244258359901559
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5247506270017716
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5262812274006292
PG2020_Intensity CT_C,,0.5117705273716442
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.5217770916586404
KBE2022_Log2_Ex_39_U,,0.5255599938907097
EP2017_Untreated R#3 log2 ratio,,0.5265218097880621
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.546316174289791
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5251265965696068
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.5215839883090092
CR2017_Ratio Replicate 2.3,,0.5399522000022038
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5261433370846639
YA2020_Reporter_intensity_Normal_No.2,0.3104765488236524,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.525922237706832
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5264383268350195
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.5302777501389854
CK2022_2 16-1,,0.5259250262747376
RAM2015_Log2 B,,0.5370423898992929
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5248285142811513
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5239125527744393
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.5147732487256166
WZ2023_Su_025_30min,,0.5207839007819957
AH2018_LFQ_4_N,,0.5251351637614231
CR2017_Ratio Replicate 1.2,,0.5320054807650907
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5175328716718095
AH2018_SILAC_M_1_X,,0.5148099902086172
RB2022_7_PreEndurance,,0.5255991799073785
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5247099174775146
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5267009738914894
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5307402566454144
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.5240504910442748
KS2014_Intensity C5,,0.5369061954664233
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.5247745990626097
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5264101942008964
RB2022_3_PostStrength,,0.5233419447054171
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5269161975578968
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5185424181425538
AH2018_LFQ_2_X,,0.5258353961565216
PG2020_Intensity 2h_B,,0.5234464273687308
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.5435958100582424
GF2025_P3_Sph,,0.5246054239955741
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.523531430517366
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5217309954389313
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.5251190701324024
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5213631030954413
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5179343421226935
ZQ2022_N1,,0.5280909054476305
LY2019_P6-,,0.5227634610408398
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5277752170025509
AH2018_LFQ_3_N,,0.5267062057466246
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.528323635717183
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.5253449304549059
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5147799279213733
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.526051804104625
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.5188473451923247
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5230677385765451
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5258867518368121
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5232607193162345
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.5212192353608095
PG2020_Intensity 10h_D,,0.5279290940910742
RB2022_8_PreEndurance,,0.5247965951802409
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.5236841352424668
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5224044650686697
EP2017_Pervanadate R#3 log2 ratio,,0.5320344699104628
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.523604016098881
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5255118600369306
AH2018_LFQ_M_4_C,,0.5258296154846211
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5243890366117452
CK2022_6 40-1,,0.5251281811133923
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.525427305285191
LY2019_P3-,,0.5270397823276123
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.522061567514845
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.5142987950951575
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.5240102418304227
AST2020_Control.1,,0.5201544509726783
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5142596697288196
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.5211606024658765
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5257492550443623
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5205369084208455
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5301611250508946
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.524549012313063
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5205435849384397
LY2019_P8+,,0.5306757455554652
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5250862178461319
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5239791598784088
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5258219057448977
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5249344759940542
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.520189246959083
LY2019_P2-,,0.5152282807096408
AH2018_LFQ_IT_1_X,,0.5179171720634181
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.5262050794707821
WZ2023_Pe_005_20min,,0.5153950144510674
AST2020_Control.2,,0.5197448439762441
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.5219594187810407
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5236698806700913
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,0.524629005338328
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5220563143647327
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5270385838196245
AH2018_TMTMS3_3_N,,0.5300438412941104
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5262924316634993
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.5265064950632976
KBE2022_Log2_Ex_36_T,,0.527906682911727
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.5203887814298704
KS2014_Intensity C2,0.30754690104780574,0.536977032859985
FSO2013_Ratio H/L normalized Rep1___2,,0.5253046452132396
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.5255027950952098
CK2022_9 200-1,,0.5357591426957394
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5358337654699049
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5407241254823284
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.5371166946183401
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5410695044732216
ZQ2022_C3,,0.5244304407643097
EJN2021_3_Rest_Ins,,0.5230621883359631
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.525688488443332
FSO2013_Ratio H/M normalized Rep3___2,,0.5312386369157716
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5321306856604928
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5158738161041614
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.3065024021285071,0.5264570657266664
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5142740618804159
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5248526560287392
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.5226149960873786
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5256324045418045
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.5212660928273688
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5224135369751784
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.5381995192861146
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.5257740357059096
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.5196617617921346
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.5148432518817213
KBE2022_Log2_Ex_29_U,,0.5276104564830659
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5276403149880571
AH2018_LFQ_IT_4_N,,0.5215508094708108
CK2022_15 200-1,,0.5252286757791207
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.53391955757982
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5218043955756948
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.527202889953829
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.5193440263676367
RN2012_H01,,0.525310795692727
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.5235912241582309
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5301583497705215
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.3101611472857604,
KBE2022_Log2_Ex_44_U,,0.5315514531697266
WZ2023_Pe_010_20min,,0.516957423563456
KS2014_Intensity pY_C6,,0.5245234638885654
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.5217525003324496
RB2022_3_PreStrength,,0.5260394107437105
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.524595863134443
KS2014_Intensity C1,,0.5339546601504118
FSO2013_Ratio H/M normalized Rep3___1,,0.530972579412911
AH2018_SILAC_M_3_C,,0.5238548670394052
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5242511010484503
AH2018_SILAC_M_2_X,,0.5207483324782896
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5267603207253401
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.5189582645519945
PG2020_Intensity 6h_C,,0.5230320944972484
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5276911787321206
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5212381215608836
CK2022_15 16-1,,0.5252591591986125
CK2022_3 16-1,,0.5260414356459953
LY2019_P4-,,0.5227601989546622
FSO2013_Ratio H/L normalized Rep3___2,,0.5300166062534948
KS2014_Intensity pY_PV2,,0.5198941408531187
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5278012130001994
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.528435752490197
CK2022_10 16-1,,0.526240250798518
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5221771604985199
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5277901439739503
EJN2021_2_Ex_Basal,,0.5237340435105692
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5206712608241959
AR2021_L41 10 μM,,0.5206620795143421
CF2017_EOC 2,,0.527801500605095
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5216683715007857
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.5258968059635212
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.522943098333917
ZX2022_CB treated Replicate 1,,0.5267661086128497
BS2014_Log2(Ratio H/L normalized Rep_3),,0.5183239658435465
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.5339203252786472
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5223240744310406
AR2021_L41 1 μM,,0.5220794715733239
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5209279992058754
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5273065769486981
KS2014_Intensity C4,,0.5338486763295262
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.526938292304846
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.5296519674632668
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5279714448318582
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.3110951694381926,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.5260028246440211
AH2018_SILAC_IT_3_C,,0.5206359677085795
WZ2023_Pu_025_10min,,0.51827058787975
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.531543716570402
FSO2013_Ratio M/L normalized Rep3___1,,0.5264946488635746
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5236766818036934
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.5156383629223151
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5245808409457635
KS2014_Intensity C6,0.30448973794407497,0.5344295373349932
ZQ2022_N3,,0.5284786780876143
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5242106433205345
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5294661530755775
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5230117956982591
AH2018_SILAC_IT_2_C,,0.5173049369717896
CK2022_5 40-1,,0.5253248477510878
AH2018_LFQ_3_X,,0.5257694716523583
UK2020_UA_3,,
LY2019_P7-,,0.5279300265224082
GF2025_P5_Adh,,0.5284473881815893
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5316092363189006
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5325056672318622
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5264099425930068
ZQ2022_C1,,0.526302262884313
CR2017_Ratio Replicate 2.1,,0.5206606754055924
PG2020_Intensity CT_B,,0.5239481695168571
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5233358454482894
KS2014_Intensity pY_E5_1,,0.5243230290333054
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.5321756637753544
AH2018_LFQ_3_C,,0.525817546104351
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.527891414057805
YA2020_Reporter_intensity_Cancer_No.4,0.3090716862822232,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5312887499499453
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.5355127834034822
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.5254703310172605
AST2020_anti-CD3+PDL2,,0.5198037901156468
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5281497035175895
KS2014_Intensity pY_N1,,0.5252900105715275
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5236394501996167
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.5275163320739271
AH2018_TMTMS2_1_X,,0.5195161136020517
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.5234603032594266
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.5235745196053665
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.5275945827974466
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5228117929971429
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5178956761021959
PG2020_Intensity 10h_B,,0.5278280955559831
AH2018_TMTMS3_1_X,,0.5301103864316998
CF2017_FTE 14,,0.5268151971541922
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5212535559152727
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.5290312930373265
EP2017_Untreated R#2 normalized log2 ratio,,0.5315389872722458
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5246290040645843
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.5299734942795814
AS2011_Ratio H/L Normalized RNAi_2_1,,
